Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
Ginkgo Bioworks Holdings (DNA) Ownership - Who Owns Ginkgo Bioworks Holdings?
1,809 Followers
Ginkgo Bioworks Holdings (DNA) Ownership Overview
8.68% Insiders
11.47% Mutual Funds
71.72% Other Institutional Investors
8.13% Public Companies and Individual Investors
The ownership structure of Ginkgo Bioworks Holdings (DNA) stock is a mix of institutional, retail and individual investors. Approximately 83.19% of the company’s stock is owned by Institutional Investors, 8.68% is owned by Insiders and 8.13% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 16, 2024 | Shyam Sankar Director | Bought | $512500 |
| May 14, 2024 | Marijn Dekkers Director | Sold | $1606162 |
| May 14, 2024 | Harry Sloan Director | Bought | $270833 |
| May 22, 2023 | Shyam Sankar Director | Bought | $512000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Sold | $28160 | |
| Mar 31, 2024 | Bought | $40562 | |
| Mar 31, 2024 | Sold | $65970 | |
| Mar 31, 2024 | Bought | $437793 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 189,606,908 | Institution | 11.09% | 152,633,561 | |
| 184,082,969 | Institution | 10.77% | 148,186,790 | |
| 143,085,126 | Institution | 8.37% | 115,183,526 | |
| 125,415,160 | Institution | 7.34% | 100,959,204 | |
| 122,797,533 | Institution | 7.19% | 98,852,014 | |
| 69,854,593 | Institution | 4.09% | 56,232,947 | |
| 29,762,982 | Institution | 1.74% | 23,959,201 | |
| 24,000,000 | Institution | 1.40% | 19,320,000 | |
| 21,897,921 | Institution | 1.28% | 17,627,826 | |
| 12,477,496 | Institution | 0.73% | 10,044,384 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 122,797,533 | Institution | 7.19% | 98,852,014 | |
| 21,897,921 | Institution | 1.28% | 17,627,826 | |
| 12,477,496 | Institution | 0.73% | 10,044,384 | |
| 6,634,647 | Institution | 0.39% | 5,340,891 | |
| 4,286,719 | Institution | 0.25% | 3,450,809 | |
| 3,689,494 | Institution | 0.22% | 2,970,043 | |
| 3,068,952 | Institution | 0.18% | 2,470,506 | |
| 2,111,462 | Institution | 0.12% | 1,699,727 | |
| 1,977,135 | Institution | 0.12% | 1,591,594 | |
| 1,905,707 | Institution | 0.11% | 1,534,094 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 130,229,733 | Institution | 7.62% | 104,913,073 | |
| 53,853,236 | Institution | 3.15% | 43,384,167 | |
| 44,824,688 | Institution | 2.62% | 39,943,279 | |
| 35,022,038 | Institution | 2.05% | 31,208,138 | |
| 20,098,214 | Institution | 1.18% | 17,909,519 | |
| 19,787,576 | Institution | 1.16% | 17,632,709 | |
| 9,828,398 | Institution | 0.58% | 8,246,026 | |
| 9,387,157 | Institution | 0.55% | 7,875,825 | |
| 6,360,736 | Institution | 0.37% | 5,336,658 | |
| 4,750,708 | Institution | 0.28% | 3,985,844 |
FAQ
Who Owns Ginkgo Bioworks Holdings (DNA)?
According to the latest TipRanks data, approximately 71.72% of the company's stock is held by institutional investors, 8.68% is held by insiders, and 8.13% is held by retail investors.
What percentage of Ginkgo Bioworks Holdings (DNA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 71.72% of Ginkgo Bioworks Holdings (DNA) stock is held by institutional investors.
What percentage of Ginkgo Bioworks Holdings (DNA) stock is held by retail investors?
According to the latest TipRanks data, approximately 8.13% of Ginkgo Bioworks Holdings (DNA) stock is held by retail investors.
Who owns the most shares of Ginkgo Bioworks Holdings (DNA)?
Cathie Wood owns the most shares of Ginkgo Bioworks Holdings (DNA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.